UNH Stock Recent News
UNH LATEST HEADLINES
The Investment Committee give you their top stocks to watch for the second half.
When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential of their blockbuster weight management treatments, including Mounjaro, Zepbound, Ozempic, and Wegovy. While these drugs are likely to lead to billions in revenue, Lilly and Novo aren't relying solely on these drugs to grow their businesses.
UnitedHealth: Pivotal Changes Underway
UnitedHealth Group's health services segment, Optum Health, will be led by Patrick Conway, according to an internal company memo.
Key Points in This Article: UnitedHealth Group (UNH) has plummeted nearly 52% from its April peak, driven by a rare series of cataclysmic events.
SAN FRANCISCO , June 26, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises UnitedHealth Group investors that the firm is investigating potential legal claims following revelations that the company is under criminal investigation for fraud and allegedly made false statements to investors. Current shareholders are encouraged to contact the firm.
The stock of UnitedHealth Group (UNH -1.09%) is trading around its five-year lows. It plummeted after posting poor earnings numbers earlier this year amid rising costs.
The market is overestimating the negative impact of policy crackdowns, DoJ investigations, and Medicare/Medicaid cuts on UnitedHealth Group's long-term fundamentals. While legislative and regulatory headwinds will likely compress margins and slow growth, UNH's diversified business model and strong market position provide resilience and upside potential. Optum Insights is a key growth catalyst, with double-digit margin expansion and AI-driven healthcare analytics offsetting weakness in other segments.
These dividend stocks have the potential to double your investment in the next five years.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?